Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression
Background/Aims: Platinum-based chemotherapy is one of the most important strategies for treatment of colorectal cancer. To improve the therapeutic efficiency, adjuvant drugs were sought to sensitize colorectal cancer cells to platinum-based agents such as cisplatin. As previous research has shown t...
Main Authors: | Luyao Zhang, Liang He, Hua Zhang, Yan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-06-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/490834 |
Similar Items
-
MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
by: Lin Z, et al.
Published: (2020-08-01) -
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Julia C. F. Quintanilha, et al.
Published: (2021-05-01) -
Curcumin Induced Human Gastric Cancer BGC-823 Cells Apoptosis by ROS-Mediated ASK1-MKK4-JNK Stress Signaling Pathway
by: Tao Liang, et al.
Published: (2014-09-01) -
Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin
by: Su X, et al.
Published: (2020-01-01) -
MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin
by: Fangfang Jiang, et al.
Published: (2014-12-01)